Evidence mapPaperPMID 19082851Full record

Trial reportLipids2009

Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet.

Jeff S Volek, Stephen D Phinney, Cassandra E Forsythe, Erin E Quann, Richard J Wood, Michael J Puglisi, William J Kraemer, Doug M Bibus, Maria Luz Fernandez, Richard D Feinman

3 registry-linked trialsAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Lipids, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 182 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
182citing papers in PubMed, 10 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02263183 naunknown statusnot on this mapstarted 2013, after this paper: background citation

Red Palm Olein and Cardiovascular Health

TypeinterventionalSponsorMalaysia Palm Oil BoardRan2013 to 2017Enrolled53ConditionsCardiovascular Risk FactorArmsRed Palm Olein, Palm Olein
NCT02519309 nacompletednot on this mapstarted 2015, after this paper: background citation

Dietary Intervention in Type-2 Diabetics and Pre-Diabetics Emphasizing Personalized Carbohydrate Intake

TypeinterventionalSponsorVirta HealthRan2015 to 2021Enrolled465ConditionsDiabetes Mellitus, Type 2, Pre-diabetes, Metabolic SyndromeArmsVirta Program
NCT02922062 nacompletednot on this mapstarted 2016, after this paper: background citation

The Effects of Palm Oil Consumed Under Different Macronutrient Distributions on Circulating Lipoprotein and Fatty Acid Profiles

TypeinterventionalSponsorOhio State UniversityRan2016 to 2018Enrolled24ConditionsCardiovascular Diseases, InflammationArmsCanola Oil, Palm Oil, Butter
3 · Its place in the literature

Who cites it

182 citing papers in PubMed, 10 syntheses or guidelines pooled it, 397 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Dietary magnesium intake and risk of metabolic syndrome: a meta-analysis.Diabetic medicine : a journal of the British Diabetic Association · 2014
    Pooled it
  11. Trial
  12. RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

122 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jeff S VolekDepartment of Kinesiology, University of Connecticut, 2095 Hillside Road, Storrs, CT 06269-1110, USA. jeff.volek@uconn.edu
Stephen D Phinney
Cassandra E Forsythe
Erin E Quann
Richard J Wood
Michael J Puglisi
William J Kraemer
Doug M Bibus
Maria Luz Fernandez
Richard D Feinman
University of Connecticut · USUniversity of California, Davis · USLucid Technologies (United States) · USSUNY Downstate Health Sciences University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently proposed that the biological markers improved by carbohydrate restriction were precisely those that define the metabolic syndrome (MetS), and that the common thread was regulation of insulin as a control element. We specifically tested the idea with a 12-week study comparing two hypocaloric diets (approximately 1,500 kcal): a carbohydrate-restricted diet (CRD) (%carbohydrate:fat:protein = 12:59:28) and a low-fat diet (LFD) (56:24:20) in 40 subjects with atherogenic dyslipidemia. Both interventions led to improvements in several metabolic markers, but subjects following the CRD had consistently reduced glucose (-12%) and insulin (-50%) concentrations, insulin sensitivity (-55%), weight loss (-10%), decreased adiposity (-14%), and more favorable triacylglycerol (TAG) (-51%), HDL-C (13%) and total cholesterol/HDL-C ratio (-14%) responses. In addition to these markers for MetS, the CRD subjects showed more favorable responses to alternative indicators of cardiovascular risk: postprandial lipemia (-47%), the Apo B/Apo A-1 ratio (-16%), and LDL particle distribution. Despite a threefold higher intake of dietary saturated fat during the CRD, saturated fatty acids in TAG and cholesteryl ester were significantly decreased, as was palmitoleic acid (16:1n-7), an endogenous marker of lipogenesis, compared to subjects consuming the LFD. Serum retinol binding protein 4 has been linked to insulin-resistant states, and only the CRD decreased this marker (-20%). The findings provide support for unifying the disparate markers of MetS and for the proposed intimate connection with dietary carbohydrate. The results support the use of dietary carbohydrate restriction as an effective approach to improve features of MetS and cardiovascular risk.

Indexed as

AdolescentAdultBlood GlucoseBody CompositionBody Mass IndexCaloric RestrictionDietary CarbohydratesDietary FatsFemaleHumansInsulinMaleMetabolic SyndromeMiddle AgedBlood GlucoseDietary CarbohydratesDietary FatsInsulin

Identifiers

PMID19082851
OpenAlexW2074560199

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.